Related references
Note: Only part of the references are listed.Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design
Naga P. Chalasani et al.
CONTEMPORARY CLINICAL TRIALS (2009)
Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression
Geoffrey C. Farrell et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Cellular and molecular mechanisms of liver injury
Harmeet Malhi et al.
GASTROENTEROLOGY (2008)
The Role of the Antioxidants Lycopene and Vitamin E in the Prevention of Halothane-Induced Hepatotoxicity
Azize Bestas et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2008)
Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet
Maiana Verdelho Machado et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease
Janice Jou et al.
SEMINARS IN LIVER DISEASE (2008)
Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats
Christine M. Crincoli et al.
TOXICOLOGY (2008)
Involvement of cytochrome P450-mediated metabolism in tienilic acid hepatotoxicity in rats
Takayoshi Nishiya et al.
TOXICOLOGY LETTERS (2008)
Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E
Hua Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis
Hideyuki Kojima et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2007)
Non-alcoholic steatohepatitis and metabolic syndrome
Mariana Machado et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2006)
Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet
T Nagasawa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
COX-2 induction in mice with experimental nutritional steatohepatitis:: Role as pro-inflammatory mediator
J Yu et al.
HEPATOLOGY (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis
Rita M. Ramalho et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2006)
NF-κB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis
A Dela Peña et al.
GASTROENTEROLOGY (2005)
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity
E Bugianesi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis
AC de Gouville et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Adiponectin and its receptors in non-alcoholic steatohepatitis
S Kaser et al.
GUT (2005)
Control of oxidative stress and reduction in biochemical markers by Vitamin E treatment in patients with nonalcoholic steatohepatitis: a pilot study
M Kawanaka et al.
HEPATOLOGY RESEARCH (2004)
How can transforming growth factor beta be targeted usefully to combat liver fibrosis?
FW Shek et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Hepatocyte apoptosis, expression of death receptors, and activation of NF-κB in the liver of nonalcoholic and alcoholic steatohepatitis patients
PS Ribeiro et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Vitamin E treatment in pediatric obesity-related liver disease: A randomized study
P Vajro et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2004)
Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways
B Antonsson
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E
M Kugelmas et al.
HEPATOLOGY (2003)
Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis
AE Feldstein et al.
GASTROENTEROLOGY (2003)
Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis:: a pilot study
T Hasegawa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
JE Lavine
JOURNAL OF PEDIATRICS (2000)